Table 1 Patient Demographic and Clinicopathologic Characteristics
All patients | 66 | |
|---|---|---|
Characteristic | ||
Sex | F | 29 (44) |
M | 37 (56) | |
Median Age [Range], years | 66 [36-85] | |
Primary surgical procedure | Whipple | 34 (51.6) |
Total Pancreatectomy | 2 (3.0) | |
Distal Pancreatectomy | 9 (13.6) | |
Open/close Surgery | 6 (9.1) | |
Excluded Surgery | 15 (22.7) | |
NAC | 13 (19.7) | |
Tumor location | Head | 49 (74.3) |
Neck | 3 (4.5) | |
Body | 8 (12.1) | |
Tail | 6 (9.1) | |
Resection margin status | R0 | 38 (57.6) |
R1 | 7 (10.6) | |
NA (aborted/excluded Surgery) | 21 (31.8) | |
Pathologic grades | Well-differentiated (G1) | 2 (3.0) |
Moderately-differentiated (G2) | 42 (63.7) | |
Poorly-differentiated (G3) | 8 (12.1) | |
Cannot be assessed (Gx) | 2 (3.0) | |
Unknown (FNA, CNB of metastasis) | 12 (18.2) | |
Lymphovascular invasion | Yes | 24 (36.4) |
No | 19 (28.8) | |
Indeterminate | 2 (3.0) | |
Unknown (aborted/excluded Surgery) | 21 (31.8) | |
Perineural invasion | Yes | 43 (65.2) |
No | 1 (1.5) | |
Indeterminate | 1 (1.5) | |
Unknown (aborted/excluded Surgery) | 21 (31.8) | |
Pathologic T stage | 1 | 3 (4.5) |
2 | 29 (44) | |
3 | 11 (16.7) | |
4 | 1 (1.5) | |
Cannot be assessed (pTx) | 1 (1.5) | |
Unknown (aborted/excluded surgery) | 21 (31.8) | |
Pathologic N stage | 0 (no regional LN metastasis) | 13 (19.7) |
1 (regional LN metastasis 1-3) | 12 (18.2) | |
2 (regional LN ≥ 4) | 20 (30.3) | |
Unknown (aborted/excluded Surgery) | 21 (31.8) | |
Pathologic stage | I | 9 (13.6) |
IIA | 4 (6.1) | |
IIB | 32 (48.5) | |
III | 1 (1.5) | |
IV | 1 (1.5) | |
Unknown (aborted/excluded Surgery) | 19 (28.8) | |
Preoperative serum CA19-9 | Normal (≤ 34 U/mL) | 10 (15.1) |
Abnormal (> 34 U/mL) | 50 (75.8) | |
Not available | 6 (9.1) |